Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2015, Article ID 186302, 3 pages
http://dx.doi.org/10.1155/2015/186302
Case Report

Systemic Steroid Treatment for Severe Expanding Pneumococcal Pneumonia

1Department of Pediatrics Mount Scopus, Hadassah-Hebrew University Medical Center, P.O. Box 24035, 91240 Jerusalem, Israel
2Department of Medical Imaging, Hadassah-Hebrew University Medical Center, Mount Scopus, P.O. Box 24035, 91240 Jerusalem, Israel

Received 8 January 2015; Accepted 23 February 2015

Academic Editor: Jonathan Muraskas

Copyright © 2015 Eran Lavi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Puren, C. Feldman, N. Savage, P. J. Becker, and C. Smith, “Patterns of cytokine expression in community-acquired pneumonia,” Chest, vol. 107, no. 5, pp. 1342–1349, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. D. van de Beek, J. de Gans, P. McIntyre, and K. Prasad, “Corticosteroids for acute bacterial meningitis,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD004405, 2007. View at Google Scholar · View at Scopus
  3. M. Briel, H. C. Bucher, R. Boscacci, and H. Furrer, “Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD006150, 2006. View at Google Scholar · View at Scopus
  4. G. P. Patel and R. A. Balk, “Systemic steroids in severe sepsis and septic shock,” American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 2, pp. 133–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. C. A. Meijvis, H. Hardeman, H. H. F. Remmelts et al., “Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 377, no. 9782, pp. 2023–2030, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Garcia-Vidal, E. Calbo, V. Pascual, C. Ferrer, S. Quintana, and J. Garau, “Effects of systemic steroids in patients with severe community-acquired pneumonia,” European Respiratory Journal, vol. 30, no. 5, pp. 951–956, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Snijders, J. M. A. Daniels, C. S. de Graaff, T. S. van der Werf, and W. G. Boersma, “Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial,” The American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 9, pp. 975–982, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Tamura, K. Matsubara, T. Tanaka, H. Nigami, K. Yura, and T. Fukaya, “Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children,” Journal of Infection, vol. 57, no. 3, pp. 223–228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. K. Weiss, M. Hall, G. E. Lee, M. P. Kronman, S. Sheffler-Collins, and S. S. Shah, “Adjunct corticosteroids in children hospitalized with community-acquired pneumonia,” Pediatrics, vol. 127, no. 2, pp. e255–e263, 2011. View at Publisher · View at Google Scholar · View at Scopus